TERUMO MEDICAL CORPORATION · Vascular Hemostasis/Closure Device · First cleared Dec 1999 · 15 device variants grouped
Total Reports
6,417
Reports (30d)
92
Active Signals
3
Open Recalls
0
Detection
Evidence
Real-World Experience With the Angio-Seal Closure Device: Insights From Manufacturer and User Facility Device Experience Database.
Ahrari A, et al. · 2023
A novel bailout technique using myocardial biopsy forceps to grasp a dislodged angio-seal collagen with footplate.
Miwa H, et al. · 2024
Predictors of Hemostasis Failure with Angio-Seal Device in a Real-World Setting for Infrainguinal Revascularization Procedures.
Alesiani F, et al. · 2025
Ultrasound-Guided vs Non–Ultrasound-Guided Angio-Seal Vascular Hemosasis After Endovascular Treatment for Peripheral Artery Disease: An Observational Study
Femke Anne Groenewegen, et al. · Journal of Endovascular Therapy · 2024
Dual ProGlide vs ProGlide and Angio-Seal for Femoral Access Hemostasis After Transcatheter Aortic Valve Replacement: A Randomised Comparative Trial
Chih‐Fan Yeh, et al. · Canadian Journal of Cardiology · 2024
Citations indexed from PubMed.
Keep exploring
Perclose ProGlide
ABBOTT VASCULAR INC. · 24,504 reports
Perclose ProStyle
ABBOTT VASCULAR INC. · 19,336 reports
PERCLOSE
ABBOTT VASCULAR INC. · 9,890 reports
SYNERGY
BOSTON SCIENTIFIC CORPORATION · 5,991 reports
Resolute Onyx
MEDTRONIC, INC. · 4,467 reports
Promus PREMIER
BOSTON SCIENTIFIC CORPORATION · 2,717 reports
Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 3 active signals detected right now.
Get Early AccessUnderstanding this data